Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Survival Tree

Survival Tree

Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a survival tree begins...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

Truncation in Survival Analysis

Truncation in Survival Analysis

Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are observed.

Censoring Survival Data

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Assumptions of Survival Analysis

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

From Five-Number Summary to Absolute Heterogeneity: Recent Methodological Advances in Meta-Analysis With Continuous Outcomes.

Journal of evidence-based medicine·2026

Same author

AI-powered digital innovations in pharmaceuticals research & development: Current landscape and case examples.

Journal of biopharmaceutical statistics·2026

Same author

Minimum distance estimation of mean and standard deviation from reported quantiles.

Research synthesis methods·2026

Same author

An Integrated Large-Scale Atlas of Protein Quantitative Trait Loci across Olink and SomaScan platforms.

medRxiv : the preprint server for health sciences·2025

Same author

Decentralized Clinical Trials in the Era of Real-World Evidence: A Critical Assessment of Recent Experiences.

Clinical and translational science·2025

Same author

Assessment of treatment effect heterogeneity for multiregional randomized clinical trials.

Statistics in biopharmaceutical research·2025

Search research articles

Related Experiment Video

Updated: May 22, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Gene selection using iterative feature elimination random forests for survival outcomes.

Herbert Pang¹, Stephen L George, Ken Hui

¹Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC 27705, USA. herbert.pang@duke.edu

IEEE/ACM Transactions on Computational Biology and Bioinformatics

|May 2, 2012

Summary

This study introduces a new random forest method for identifying prognostic genes in high-dimensional data with survival outcomes, outperforming traditional single-gene approaches.

Related Experiment Videos

Last Updated: May 22, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Area of Science:

Bioinformatics
Computational Biology
Genomics

Background:

High-dimensional data with censored survival outcomes presents challenges for gene selection.
Existing classification feature selection methods are often single-gene based and not integrated into algorithms.

Purpose of the Study:

To develop a novel, embedded gene selection method for high-dimensional data with survival outcomes.
To leverage the strengths of random forests for identifying prognostic genes.

Main Methods:

A new method based on random forests was developed for prognostic gene identification.
The novel method was compared against various machine learning techniques and node split criteria.
Simulations and real-world microarray datasets were used for evaluation.

Main Results:

The proposed random forest-based method demonstrated strong performance in both simulated and real data analyses.
The approach effectively identified a set of prognostic genes.
The method showed advantages over traditional single-gene-based approaches.

Conclusions:

The novel random forest method successfully identifies prognostic genes in high-dimensional data with survival outcomes.
This approach effectively incorporates multivariate correlations, enhancing the utilization of microarray data.
The embedded nature of the method offers advantages over non-integrated feature selection techniques.